Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 484

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 484
---
 as the representative of the Equityholders and, solely with respect to Section 1.8(a), 3.11 and Article X of the Agreement and Plan of Merger, Sorrento Therapeutics, Inc. (incorporated by reference to Exhibit 2.2 of Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025). |
|:--------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.3

#    |     | Agreement and Plan of Merger, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.3 of Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).                                                                                                                                                                                                               |
| 2.4     |     | Amendment No. 1 to Agreement and Plan of Merger, dated as of April 16, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.4 of Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).                                                                                                                                                                                             |
| 2.5     |     | Amendment No. 2 to Agreement and Plan of Merger, dated as of July 22, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.5 of Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).                                                                                                                                                                                              |
| 3.1     |     | Restated Certificate of Incorporation of Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K (File No. 001-41351), filed with the SEC on September 26, 2025).                                                                                                                                                                                                                                                                                               |
| 3.2     |     | Certificate of Designations of Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.2 of our Current Report on Form 8-K (File No. 001- 41351), filed with the SEC on